Novel Strategy Against Apoptosis-Resistant Tumors
Genetic Engineering & Biotechnology News - March 08, 2022
Evripidis Gavathiotis, Ph.D., comments on his discovery of a highly promising strategy for overcoming a key cause of cancer deaths: the ability of cancer cells to thrive in the face of chemotherapy drugs designed to destroy them. Dr. Gavathiotis is professor of biochemistry and of medicine at Einstein and co-leader of the Cancer Therapeutics Program at the NCI-designated Albert Einstein Cancer Center.
The Scientist interviews Nir Barzilai, M.D., and Evris Gavathiotis, Ph.D., about their success in pursuing private funding in the face of federal funding cuts. Drs. Barzilai and Gavathiotis share how they identified and pursued alternative funding sources and how it has helped advance their research. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research at Einstein and attending physician at Montefiore Medical Center. Dr. Gavathiotis is assistant professor of biochemistry and of medicine.
May 1, 2015